Report overview
Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.
This report contains market size and forecasts of Blood Cancer Therapeutics in Global, including the following market information:
Global Blood Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Blood Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chronic Myeloid Leukemia (CML) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Blood Cancer Therapeutics include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Novartis, Boehringer Ingelheim, Pfizer and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Blood Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Blood Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Chronic Myeloid Leukemia (CML)
Acute Lymphocytic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Acute Myeloid Leukemia (AML)
Global Blood Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Blood Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Global Blood Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Blood Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Blood Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
AstraZeneca
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Novartis
Boehringer Ingelheim
Pfizer
Sanofi
